Cited by 215Schizophrenia research and treatmentPsychiatric care and mental health servicesMental Health and Patient Involvement

The DOI matches its Crossref record; 213 of the 214 references it cites were found in a registry or an index.

Schizophrenia--Time to Commit to Policy Change

Open access

Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., Moller, M., Sartorius, N., Woodruff, P.·2014·Schizophrenia Bulletin

DOI 10.1093/schbul/sbu006PMC PMC4002061

Open this paper in CoChat — free account Open PDF

Abstract

Care and outcomes for people with schizophrenia have improved in recent years, but further progress is needed to help more individuals achieve an independent and fulfilled life. This report sets out the current need, informs policy makers and all relevant stakeholders who influence care quality, and supports their commitment to creating a better future. The authors recommend the following policy actions, based on research evidence, stakeholder consultation, and examples of best practice worldwide. (1) Provide an evidence-based, integrated care package for people with schizophrenia that addresses their mental and physical health needs. (2) Provide support for people with schizophrenia to enter and to remain in their community, and develop mechanisms to help guide them through the complex benefit and employment systems. (3) Provide concrete support, information, and educational programs to families and carers on how to enhance care for an individual living with schizophrenia in a manner that entails minimal disruption to their lives. (4) All stakeholders, including organizations that support people living with schizophrenia, should be consulted to regularly revise, update, and improve policy on the management of schizophrenia. (5) Provide support, which is proportionate to the impact of the disease, for research and development of new treatments. (6) Establish adequately funded, ongoing, and regular awareness-raising campaigns that form an integral part of routine plans of action. Implementation of the above recommendations will require engagement by every stakeholder, but with commitment from all, change can be achieved.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/schbul/sbu006

Cites

213 of 213 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia
Jones, C. A., Hacker, D., Meaden, A., Cormac, I., & Irving, C. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub3 · Cited by 97
Retracted
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,703
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Untitled work
(1996) · Cited by 6,884
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Current Cigarette Smoking Among Adults — United States, 2005–2014
Jamal, A., Homa, D. M., O’Connor, E., Babb, S. D., Caraballo, R. S., Singh, T., Hu, S., & King, B. A. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6444a2 · Cited by 2,544

Show all 214 references

Research works printed but not linked: 16

Leucht, 2012, Cochrane database of systematic reviews (Online), 5, CD008016
2013, 9, 787
Connock, 2006, Health technology assessment (Winchester, England), 10, iii
Lieberman, 2008, Psychiatric Services, 59, 487, 10.1176/appi.ps.59.5.487 · DOI
Davis, 1985, The Journal of clinical psychiatry, 46, 18
Jones, 2012, Cochrane database of systematic reviews (Online), 4, CD008712
2003, Cochrane database of systematic reviews (Online), 4, CD000088
1996, International clinical psychopharmacology, 11, 77
Dixon, 2011, Psychiatric Services, 62, 591, 10.1176/appi.ps.62.6.591 · DOI
1997, Social policy, 27, 27
Sullivan, 2006, Psychiatric Services, 57, 1126, 10.1176/appi.ps.57.8.1126 · DOI
2006, Cochrane database of systematic reviews (Online), 4, CD000453
Herman, 2011, Psychiatric Services, 62, 713, 10.1176/appi.ps.62.7.713 · DOI
2013, The journal of mental health policy and economics, 16, 81
Ryan, 2010, Psychiatric Services, 61, 469, 10.1176/appi.ps.61.5.469 · DOI
Cougnard, 2007, Psychiatric Services, 58, 1427, 10.1176/appi.ps.58.11.1427 · DOI

Sorted by citations

Schizophrenia
Marder, S. R., & Cannon, T. D. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1808803 · Cited by 571
Self-citation
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia
Galderisi, S., Rossi, A., Rocca, P., Bertolino, A., Mucci, A., Bucci, P., Rucci, P., Gibertoni, D., Aguglia, E., Amore, M., et al. (2014) · World Psychiatry · doi:10.1002/wps.20167 · Cited by 487
Self-citation
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia
Vita, A., Barlati, S., Ceraso, A., Nibbio, G., Ariu, C., Deste, G., & Wykes, T. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0620 · Cited by 503
The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
Kozloff, N., Mulsant, B. H., Stergiopoulos, V., & Voineskos, A. N. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa051 · Cited by 381
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia
Galderisi, S., Rucci, P., Kirkpatrick, B. W., Mucci, A., Gibertoni, D., Rocca, P., Rossi, A., Bertolino, A., Strauss, G. P., Aguglia, E., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4607 · Cited by 320
Self-citation
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
Self-citation
Recovery from schizophrenia: is it possible?
Vita, A., & Barlati, S. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000407 · Cited by 187
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses
Mucci, A., Galderisi, S., Gibertoni, D., Rossi, A., Rocca, P., Bertolino, A., Aguglia, E., Amore, M., Bellomo, A., Biondi, M., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4614 · Cited by 172
Self-citation
Community-based psychosocial interventions for people with schizophrenia in low and middle-income countries: systematic review and meta-analysis
Asher, L., Patel, V., & Silva, M. J. D. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1516-7 · Cited by 171
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study
Savitz, A. J., Xu, H., Gopal, S., Nuamah, I. F., Ravenstijn, P. G. M., Janik, A., Schotte, A., Hough, D. W., & Fleischhacker, W. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw018 · Cited by 160
Self-citation
The interplay among psychopathology, personal resources, context‐related factors and real‐life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non‐recovered patients
Galderisi, S., Rucci, P., Mucci, A., Rossi, A., Rocca, P., Bertolino, A., Aguglia, E., Amore, M., Bellomo, A., Bozzatello, P., et al. (2020) · World Psychiatry · doi:10.1002/wps.20700 · Cited by 148
Self-citation
Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies
Bugarski‐Kirola, D., Blaettler, T., Arango, C., Fleischhacker, W., Garibaldi, G. M., Wang, A., Dixon, M., Bressan, R. A., Nasrallah, H. A., Lawrie, S. M., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.014 · Cited by 145
Self-citation
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review
Perrottelli, A., Giordano, G. M., Brando, F., Giuliani, L., & Mucci, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.653642 · Cited by 135
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder
Oliver, L. D., Moxon‐Emre, I., Lai, M., Grennan, L., Voineskos, A. N., & Ameis, S. H. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3908 · Cited by 115
Transforming the Treatment of Schizophrenia in the United States: The RAISE Initiative
Dixon, L. B., Goldman, H. H., Srihari, V. H., & Kane, J. M. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084934 · Cited by 112
“…adding to the similar conclusions of the international literature on societal economic benefit (Alison et al. 2012) and strengthening consensus on the need for policy commitments to support further implementation and refinement of models of care (Fleischhacker et al. 2014, Lieberman et al. 2013).”
Background
Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
Durgam, S., Earley, W. R., Li, R., Li, D., Lu, K., Laszlovszky, I., Fleischhacker, W. W., & Nasrallah, H. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.030 · Cited by 103
Self-citation
The weaponization of medicine: Early psychosis in the Black community and the need for racially informed mental healthcare
Faber, S. C., Roy, A. K., Michaels, T. I., & Williams, M. T. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1098292 · Cited by 111
Wavelet transforms for feature engineering in EEG data processing: An application on Schizophrenia
Gosala, B., Kapgate, P. D., Jain, P., Chaurasia, R. N., & Gupta, M. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.104811 · Cited by 93
The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community.
Mucci, A., Rucci, P., Rocca, P., Bucci, P., Gibertoni, D., Merlotti, E., Galderisi, S., & Maj, M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.044 · Cited by 95
Self-citation
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale
Mucci, A., Vignapiano, A., Bitter, I., Austin, S. F., Delouche, C., Dollfus, S., Erfurth, A., Fleischhacker, W. W., Giordano, G. M., Олегович, Г. И., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.05.006 · Cited by 85
Self-citation
Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan
Hofer, A., Mizuno, Y., Frajo-Apor, B., Kemmler, G., Suzuki, T., Pardeller, S., Welte, A.-S., Sondermann, C., Mimura, M., Wartelsteiner, F., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.027 · Cited by 94
Self-citation
Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
Amato, D., Vernon, A. C., & Papaleo, F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.027 · Cited by 81
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
Cao, B., Chen, Y., Ren, Z., Pan, Z., McIntyre, R. S., & Wang, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.018 · Cited by 76
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services
Vita, A., & Barlati, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00147 · Cited by 79
The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia
Pong, S., Karmacharya, R., Sofman, M., Bishop, J. R., & Lizano, P. L. (2020) · Complex Psychiatry · doi:10.1159/000511552 · Cited by 74
Involvement of people with schizophrenia in decision-making in rural Ethiopia: a qualitative study
Souraya, S., Hanlon, C., & Asher, L. (2018) · Globalization and Health · doi:10.1186/s12992-018-0403-4 · Cited by 68
Improving Weight in People with Serious Mental Illness: The Effectiveness of Computerized Services with Peer Coaches
Young, A. S., Cohen, A. N., Goldberg, R. W., Hellemann, G., Kreyenbuhl, J., Niv, N., Nowlin-Finch, N., Oberman, R. S., & Whelan, F. (2017) · Journal of general internal medicine · doi:10.1007/s11606-016-3963-0 · Cited by 50
Antipsychotic-Induced Metabolic Syndrome: A Review
Akinola, S., Tardif, I., & Leclerc, J. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0003 · Cited by 60
The enduring gap in educational attainment in schizophrenia according to the past 50 years of published research: a systematic review and meta-analysis
Crossley, N. A., Alliende, L. M., Czepielewski, L. S., Aceituno, D., Castañeda, C. P., Díaz, C., Iruretagoyena, B., Mena, C., Mena, C., Ramírez-Mahaluf, J. P., et al. (2022) · The Lancet Psychiatry · doi:10.1016/s2215-0366(22)00121-3 · Cited by 54
Self-citation
Value of schizophrenia treatment I: The patient journey
Mohr, P., Galderisi, S., Boyer, P., Wasserman, D., Arteel, P., Ieven, A., Kärkkäinen, H., Pereira, E., Guldemond, N., Winkler, P., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.007 · Cited by 58
Self-citation
Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes
Fowler, D., Hodgekins, J., & French, P. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.006 · Cited by 53
Areas of interest and stigmatic attitudes of the general public in five relevant medical conditions: thematic and quantitative analysis using Twitter
Alvarez-Mon, M. A., Llavero-Valero, M., Sánchez-Bayona, R., Pereira-Sanchez, V., Vallejo-Valdivielso, M., Monserrat, J., Lahera, G., Asunsolo del Barco, A., & Alvarez-Mon, M. (2019) · Journal of Medical Internet Research · doi:10.2196/14110 · Cited by 52
Trends in big data analyses by multicenter collaborative translational research in psychiatry
Onitsuka, T., Hirano, Y., Nemoto, K., Hashimoto, N., Kushima, I., Koshiyama, D., Koeda, M., Takahashi, T., Noda, Y., Matsumoto, J., et al. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13311 · Cited by 53
Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)
Rossum, I. W.-V., Weiser, M., Galderisi, S., Leucht, S., Bitter, I., Glenthoj, B. Y., Hasan, A., Luykx, J. J., Kupchik, M., Psota, G., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00005-6 · Cited by 49
Self-citation
Psychosocial interventions in schizophrenia: Focus on guidelines
Ventriglio, A., Ricci, F., Magnifico, G., Chumakov, E. M., Torales, J. C., Watson, C. J., Castaldelli-Maia, J. M., Petito, A., & Bellomo, A. (2020) · International Journal of Social Psychiatry · doi:10.1177/0020764020934827 · Cited by 48
College students’ stigmatization of people with mental illness: familiarity, implicit person theory, and attribution
Lyndon, A. E., Crowe, A., Wuensch, K. L., McCammon, S. L., & Davis, K. B. (2016) · Journal of Mental Health · doi:10.1080/09638237.2016.1244722 · Cited by 45
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
Scheggia, D., Mastrogiacomo, R., Mereu, M., Sannino, S., Straub, R. E., Armando, M., Managò, F., Guadagna, S., Piras, F., Zhang, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04711-w · Cited by 44
Mortality and suicide in schizophrenia: 21-year follow-up in rural China
Ran, M., Xiao, Y., Fazel, S., Lee, Y., Luo, W. P., Hu, S., Yang, X., Liu, B., Brink, M., Chan, S. K. W., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.106 · Cited by 42
Mobile-Assisted Cognitive Behavioral Therapy for Negative Symptoms: Open Single-Arm Trial With Schizophrenia Patients
Granholm, E. L., Holden, J. L., Dwyer, K., Mikhael, T., Link, P. C., & Depp, C. A. (2020) · JMIR Mental Health · doi:10.2196/24406 · Cited by 40
Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Ferreira, V., Grajales, D., & Valverde, Á. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158534 · Cited by 41
Health and economic impacts of particulate matter pollution on hospital admissions for mental disorders in Chengdu, Southwestern China
Zhang, P., & Zhou, X. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139114 · Cited by 37
Specialized Consultation for Suspected Recent-onset Schizophrenia: Diagnostic Clarity and the Distorting Impact of Anxiety and Reported Auditory Hallucinations
COULTER, C., Baker, K. K., & Margolis, R. L. (2019) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000363 · Cited by 33
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques
Collo, G., Mucci, A., Giordano, G. M., Pich, E. M., & Galderisi, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00632 · Cited by 35
Self-citation
Periodontal Systemic Connections - Novel Associations : A Review of the Evidence with Implications for Medical Practitioners
Kalakonda, B., Koppolu, P., & Baroudi, K. (2016) · International Journal of Health Sciences · doi:10.12816/0048820 · Cited by 32
Psychosocial functioning in the balance between autism and psychosis: evidence from three populations
Abu-Akel, A. M., Wood, S. J., Upthegrove, R., Chisholm, K., Lin, A. P., Hansen, P., Gillespie, S. M., Apperly, I. A., & Montag, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01543-5 · Cited by 34
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses
Giuliani, L., Giordano, G. M., Bucci, P., Pezzella, P., Brando, F., & Galderisi, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.791117 · Cited by 29
Self-citation
Digital Technology for Caregivers of People With Psychosis: Systematic Review
Onwumere, J., Amaral, F., & Valmaggia, L. (2018) · JMIR Mental Health · doi:10.2196/mental.9857 · Cited by 27
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation
Correll, C. U., Jain, R., Meyer, J. M., Periclou, A. P., Carrothers, T. J., Barabássy, Á., Patel, M., & Earley, W. R. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s210340 · Cited by 27
Prolactin and Thyroid Stimulating Hormone (TSH) Levels and Sexual Dysfunction in Patients with Schizophrenia Treated with Conventional Antipsychotic Medication: A Cross-Sectional Study
Zhang, Y., Tang, Z., Ruan, Y., Huang, C., Wu, J., Lu, Z., Li, W., Tang, Y., Liu, J., She, J., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.913759 · Cited by 28
A naturalistic study on the relationship among resilient factors, psychiatric symptoms, and psychosocial functioning in a sample of residential patients with psychosis
Poloni, N., Zizolfi, D., Ielmini, M., Pagani, R., Caselli, I., Diurni, M., Milano, A., & Callegari, C. (2018) · Psychology Research and Behavior Management · doi:10.2147/prbm.s159571 · Cited by 29
The role of dopamine receptors in lymphocytes and their changes in schizophrenia
Penedo, M. A., Baltanás, T. R., Pérez-Rodríguez, D., Allen, J., Borrajo, A., Alonso-Crespo, D., Fernández-Pereira, C., Nieto-Araujo, M., Ramos-García, S., Barreiro-Villar, C., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100199 · Cited by 26
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
Giordano, G. M., Brando, F., Pezzella, P., Angelis, M. D., Mucci, A., & Galderisi, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.970210 · Cited by 28
Self-citation
Lactate levels in the brain and blood of schizophrenia patients: A systematic review and meta-analysis
Liu, S., Zhang, L., Fan, X., Wang, G., Liu, Q., Yang, Y., Shao, M., Song, M., Li, W., Lv, L., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.013 · Cited by 26
Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
Mueller, D. R., Khalesi, Z., Benzing, V., Castiglione, C. I., & Roder, V. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.037 · Cited by 25
Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target
Rodrígues-Amorím, D., Baltanás, T. R., Fernández-Palleiro, P., Iglesias‐Martínez‐Almeida, M., Freiría‐Martínez, L., Rodríguez-Jamardo, C., Vallejo-Curto, M. D. C., Álvarez-Ariza, M., López-García, M., Heras, E. D. L., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01073-8 · Cited by 23
Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions
Brandt, S. J., Oral, H. Y., Arellano-Bravo, C., Plawecki, M. H., Hummer, T. A., & Francis, M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01046-1 · Cited by 23
Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (−141 C Ins/Del) and 5HTR2C (−759 C>T) Genetic Polymorphisms in Patients with Schizophrenia
Goud, A. C., Mohan, A., Shewade, D. G., Rajkumar, R. P., Adithan, C., & Subramanian, K. (2017) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/jpp.jpp_197_16 · Cited by 22
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Calzavara‐Pinton, I., Nibbio, G., Barlati, S., Bertoni, L., Necchini, N., Zardini, D., Baglioni, A., Paolini, S., Poddighe, L., Bulgari, V., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14080791 · Cited by 23
Schizophrenia and “unmet needs”: From diagnosis to care in Italy
Galderisi, S., Riva, M. A., Girardi, P., Amore, M., Carpiniello, B., Aguglia, E., Fagiolini, A. M., Mucci, A., & Vita, A. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2019.8 · Cited by 21
Self-citation
The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations
Arango, C., Buitelaar, J. K., Correll, C. U., Díaz‐Caneja, C. M., Figueira, M. L., Fleischhacker, W. W., Marcotulli, D., Parellada, M., & Vitiello, B. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.04.005 · Cited by 25
Self-citation
Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.09.001 · Cited by 28
Self-citation
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity
Bechi, M., Abu-Akel, A. M., Agostoni, G., Bosia, M., Cocchi, F., Spangaro, M., & Cavallaro, R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.044 · Cited by 20
Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study
Huerta-Ramos, E., Escobar-Villegas, M. S., Rubinstein, K., Unoka, Z. S., Grasa, E., Hospedales, M., Jääskeläinen, E., Rubio-Abadal, E., Caspi, A., Bitter, I., et al. (2016) · JMIR mHealth and uHealth · doi:10.2196/mhealth.5716 · Cited by 20
Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia
Morozova, A. Y., Zorkina, Y., Ka, P., Pavlova, O., Storozheva, Z. I., Zubkov, E. A., Zakharova, N. V., Karpenko, O., Reznik, A. M., Chekhonin, V. P., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00830 · Cited by 20
Investigating the shared genetic architecture between schizophrenia and body mass index
Yu, Y., Fu, Y., Yu, Y., Tang, M., Sun, Y., Wang, Y., Zhang, K., Li, H., Guo, H., Wang, B., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02104-0 · Cited by 22
Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial
Sampedro, A., Peña, J., Sánchez, P., Ibarretxe‐Bilbao, N., Gómez‐Gastiasoro, A., Iriarte‐Yoller, N., Pavón, C., Tous‐Espelosin, M., & Ojeda, N. (2021) · Schizophrenia · doi:10.1038/s41537-021-00181-0 · Cited by 19
Trajectories of patients with severe mental illness in two-year contact with Flexible Assertive Community Treatment teams using Routine Outcome Monitoring data: An observational study
Kortrijk, H. E., Schaefer, B., van Weeghel, J., Mulder, C. L., & Kamperman, A. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207680 · Cited by 16
Transcranial direct current stimulation for auditory verbal hallucinations: a systematic review of clinical trials
Hao, Y., Yadollahpour, A., Rashidi, S., Jones, M., Murillo‐Rodríguez, E., & Machado, S. E. D. C. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295315 · Cited by 16
Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate
Lin, D., Pilon, D., Zhdanava, M., Joshi, K., Lafeuille, M., Côté‐Sergent, A., Vermette-Laforme, M., & Lefèbvre, P. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1882412 · Cited by 16
Clinical insight and cognitive functioning as mediators in the relationships between symptoms of psychosis, depression, and suicide ideation in first-episode psychosis
Bornheimer, L. A., Cobia, D. J., Verdugo, J. L., Holzworth, J., & Smith, M. J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.006 · Cited by 19
Effectiveness of sensory modulation for people with schizophrenia: A multisite quantitative prospective cohort study
Machingura, T., Shum, D., Lloyd, C., Murphy, K. A., Rathbone, E. N., & Green, H. J. (2022) · Australian Occupational Therapy Journal · doi:10.1111/1440-1630.12803 · Cited by 15
Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study
Li, C., Shi, Z., Ji, J., Niu, G., & Liu, Z. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s322005 · Cited by 15
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning
Giordano, G. M., Giuliani, L., Perrottelli, A., Bucci, P., Lorenzo, G. D., Siracusano, A., Brando, F., Pezzella, P., Fabrazzo, M., Altamura, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245838 · Cited by 15
Self-citation
Integrated treatment of schizophrenia
Altamura, A. C., Fagiolini, A. M., Galderisi, S., Rocca, P., & Rossi, A. (2015) · Use Siena air (University of Siena) · Cited by 14
Self-citation
Sleep disturbances are associated with psychosis in schizophrenia spectrum Disorders: An umbrella review
Azargoonjahromi, A., & Bahrampour, Z. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.106690 · Cited by 20
Psychiatric and non-psychiatric polypharmacy among older adults with schizophrenia: Trends from a population-based study between 2000 and 2016
Lunghi, C., Rochette, L., Massamba, V. K., Tardif, I., Ouali, A., & Sirois, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1080073 · Cited by 15
Lowered serum cesium levels in schizophrenia: association with immune-inflammatory biomarkers and cognitive impairments
Almulla, A. F., Moustafa, S. R., Al-Dujaili, A. H., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0908 · Cited by 14
Effect of individualized occupational therapy on social functioning in patients with schizophrenia: A five-year follow-up of a randomized controlled trial
Shimada, T., Inagaki, Y., Shimooka, Y., Kawano, K., Tanaka, S., & Kobayashi, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.066 · Cited by 14
The Effect of Accelerated Continuous Theta Burst Stimulation on Weight Loss in Overweight Individuals With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial
Kang, D., Zhang, Y., Wu, G., Song, C., Peng, X., Long, Y., Guo, Y., Tang, H., Gui, Y., Wang, Q., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad144 · Cited by 13
System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis
Bhuiyan, P., Sun, Z., Khan, M. A., Hossain, M. A., Rahman, M. H., & Qian, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25191 · Cited by 14
“Being There” vs “Being Direct:” Perspectives of Persons with Serious Mental Illness on Receiving Support with Physical Health from Peer and Non-Peer Providers
Bochicchio, L. A., Stefancic, A., Mctavish, C., Tuda, D., & Cabassa, L. (2021) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-020-01098-z · Cited by 9
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project
Crespo‐Facorro, B., Bernardo, M., Argimón, J. M., Arrojo, M., Bravo‐Ortiz, M. F., Cabrera-Cifuentes, A., Román, J. C., Franco, M., García‐Portilla, M. P., Haro, J. M., et al. (2017) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.09.002 · Cited by 13
Self-citation
Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives
Guo, J., He, C.-Y., Song, H., Gao, H., Yao, S., Dong, S., & Yang, T. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01214-1 · Cited by 12
Genetic aspects of schizophrenia
Morozova, A. Y., Zubkov, E. A., Zorkina, Y., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201711761126-132 · Cited by 12
Factors that Affect Choice of Mental Health Provider and Receipt of Outpatient Mental Health Treatment
Jones, J. M., Ali, M. M., Mutter, R. L., Henke, R. M., Gokhale, M., Marder, W. D., & Mark, T. L. (2017) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-017-9575-6 · Cited by 12
The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial
Kang, D., Song, C., Peng, X., Guo, Y., Yang, Y., Chen, C., Long, Y., Shao, P., & Wu, R. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02770-w · Cited by 12
DHF-7 Ameliorates Behavioral Disorders and White Matter Lesions by Regulating BDNF and Fyn in a Mouse Model of Schizophrenia Induced by Cuprizone and MK-801
Sun, Z., Ma, D., Gu, L.-H., Chen, X., Zhang, L., & Li, L. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac022 · Cited by 11
Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review
Leber, A., Ramachandra, R., Ceban, F., Kwan, A. T. H., Rhee, T. G., Wu, J., Cao, B., Jawad, M. Y., Teopiz, K. M., Ho, R., et al. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2334424 · Cited by 11
Trial-Based Economic Evaluations of Supported Employment for Adults with Severe Mental Illness: A Systematic Review
Zheng, K., Stern, B. Z., Wafford, Q. E., & Kohli-Lynch, C. N. (2022) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-021-01174-y · Cited by 11
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review
Lisoni, J., Nibbio, G., Baglioni, A., Dini, S., Manera, B., Maccari, A., Altieri, L., Calzavara‐Pinton, I., Zucchetti, A., Deste, G., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14111067 · Cited by 10
Progress in mechanistically novel treatments for schizophrenia
Neef, J., & Palacios, D. S. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00096a · Cited by 10
Employment-Related Factors of Forensic Psychiatric Outpatients with Psychotic Disorders
Takeda, K., Sugawara, N., Yamada, Y., Nagata, T., Kashiwagi, H., Kono, T., Hirabayashi, N., & Okada, T. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s228916 · Cited by 10
Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial
Yamanushi, A., Shimada, T., Koizumi, A., & Kobayashi, M. (2024) · Biomedicines · doi:10.3390/biomedicines12071498 · Cited by 10
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia
Giuliani, L., Sanmarchi, F., Mucci, A., Rucci, P., Caporusso, E., Bucci, P., Giordano, G. M., Amore, M., Rocca, P., Rossi, A., et al. (2025) · Schizophrenia · doi:10.1038/s41537-024-00545-2 · Cited by 9
Self-citation
Real-World Functioning in Psychiatric Outpatients: Predictive Factors
Bozzatello, P., Giordano, B., Montemagni, C., Rocca, P., & Bellino, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154400 · Cited by 9
Altered functional dynamics gradient in schizophrenia with cigarette smoking
Chen, Y. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad030 · Cited by 9
Serum Levels of HCY, MIF, and hs-CRP Correlate with Glycolipid Metabolism in Adults with Never-Medicated First-Episode Schizophrenia
Zhong, X. Y., Ao, Q., & Xing, F. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/7394699 · Cited by 8
Retracted
Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents – Design, synthesis, structural studies and pharmacological profiling
Stępnicki, P., Targowska‐Duda, K. M., Martínez, A. L., Zięba, A., Wronikowska‐Denysiuk, O., Wróbel, M. Z., Bartyzel, A., Trzpil, A., Wróbel, T. M., Chodkowski, A., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115285 · Cited by 8
Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study
Cordova, V., Teixeira, A. D., Anzolin, A. P., Moschetta, R., & Belmonte-de-Abreu, P. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1269322 · Cited by 8
Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial
Shimada, T., Morimoto, T., Nagayama, H., Nakamura, N., Aisu, K., Kito, A., Kojima, R., Yamanushi, A., Kawano, K., Hikita, N., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.04.018 · Cited by 9

Authors: Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., Moller, M., Sartorius, N., & Woodruff, P.
Affiliations: Innsbruck Medical University (AT)
Hospital General Universitario Gregorio Marañón (ES)
Global Alliance of Mental Illness Advocacy Networks-Europe (BE)
West London Mental Health NHS Trust (GB)
University of Maryland, Baltimore (US)
National Alliance on Mental Illness (US)
University of Campania "Luigi Vanvitelli" (IT)
King's College London (GB)
Yale University (US)
Royal College of Psychiatrists (GB)
Corresponding author: Fleischhacker, W. W.
ORCID: Arango, C.
Carpenter, W.
Galderisi, S.
Knapp, M.
Marder, S. R.
Sartorius, N.
Woodruff, P.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 2014-04-01
Volume: 40
Issue: Suppl 3
Pages: S165-S194
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/schbul/sbu006
PMC: PMC4002061
OpenAlex: W2153297237
Cited by: 214
References: 214
Citations by year: 2026: 6 · 2025: 21 · 2024: 31 · 2023: 26 · 2022: 24 · 2021: 31 · 2020: 21 · 2019: 15 · 2018: 11 · 2017: 13 · 2016: 10 · 2015: 2 · 2014: 3
FWCI: 7.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Schizophrenia Bulletin (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
Keywords: schizophrenia, mental health policy
MeSH terms: Community Mental Health Services, Family Therapy, Health Policy, Humans, Patient Education as Topic, Psychotherapy, Quality of Life, Schizophrenia, Social Support, Antipsychotic Agents, Cognitive Behavioral Therapy, Employment, Supported, Evidence-Based Medicine, Recovery of Function, Independent Living

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia--Time to Commit to Policy Change

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks